50,937 results on '"infliximab"'
Search Results
2. A Study to Assess the Efficacy and Safety of Golimumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis (PURSUIT 2)
3. A Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients With Inflammatory Bowel Disease (DEVELOP)
4. Efficacy and Safety of Formulation Switching Between SC Infliximab and IV Infliximab in Patients With CD (CHAMELEON)
5. TDM-based Infliximab Treatment for Active Perianal Fistulizing Crohn's Disease
6. Prevention of Postoperative Endoscopic Recurrence With Endoscopy-driven Versus Systematic Biological Therapy (SOPRANO-CD)
7. Pharmacokinetics of IFX and TNF Concentrations in Serum, Stool, and Colonic Mucosa in Acute Severe Ulcerative Colitis (PROTOS)
8. MIS-C Comparative Effectiveness Study (MISTIC)
9. Infliximab or Vedolizumab in Treating Immune Checkpoint Inhibitor-Related Colitis in Patients With Genitourinary Cancer or Melanoma
10. Anti-Inflammatory Challenge in Schizophrenia
11. Infliximab Biosimilar for Intravenous Drip Infusion 100 mg "Pfizer" Drug Use Investigation (Rheumatoid Arthritis)
12. Subcutaneous Infliximab After A Previous Intravenous Dose Optimization (AMARETTO)
13. Korean College of Rheumatology Biologics and Targeted Therapy Registry (KOBIO)
14. Switching From Intravenous to Subcutaneous Infliximab in Adult Patients With Inflammatory Bowel Disease (SHUFFLE)
15. Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease (CAMEO)
16. This is a Retrospective Observational Study Looking at the Characteristics and Outcomes of Participants Taking Inflectra Using the CorEvitas Rheumatoid Arthritis Registry
17. Post-marketing Registry Study of Infliximab for Injection in Chinese Pediatric Crohn's Disease Patients
18. Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS) (POPS or POP02)
19. Infliximab-induced amicrobial pustulosis of the folds in a patient with Crohn disease
20. Infliximab and Adalimumab in Inflammatory Bowel Disease Patients.
21. Infliximab and Intravenous Immunoglobulin Therapy in Treating Patients With Steroid-Refractory Pneumonitis
22. Infliximab Biosimilar for Intravenous Drip Infusion 100 mg "Pfizer" Drug Use Investigation (Psoriasis)
23. Comparison Between Infliximab and Adalimumab on Patients With Ulcerative Colitis
24. Infliximab for Treatment of Immune Checkpoint Inhibitor Colitis
25. BackToBasic: Infliximab in Chronic Low Back Pain and Modic Changes
26. Precise Infliximab Exposure and Pharmacodynamic Control (REMODEL-CD)
27. Top-down Infliximab Study in Kids With Crohn's Disease (TISKids)
28. Infliximab Biosimilar "Pfizer" Drug Use Investigation (Crohn's Disease or Ulcerative Colitis)
29. Top Down Versus Step up in Pediatric Ulcerative Colitis
30. Stopping TNF Alpha Inhibitors in Rheumatoid Arthritis (STARA)
31. Topical Infliximab for Sterile Corneal Melt
32. Efficacy of Remission-induction Regimen With Infliximab for Severe Extrathoracic Sarcoidosis (EFIRTES) (EFIRTES)
33. CHronic Nonbacterial Osteomyelitis International Registry (CHOIR) (CHOIR)
34. Precision Crohn's Disease Management Utilizing Predictive Protein Panels (ENvISION) (ENvISION)
35. A 24-month Real Life PErsistence Efficacy and Safety Study in IBD Patients in REMission Switched From Intravenous Infliximab to Subcutaneous Infliximab CT-P13 Remsima®SC (PEREM)
36. Proactive Infliximab Optimization Using a Pharmacokinetic Dashboard Versus Standard of Care in Patients With Inflammatory Bowel Disease: The OPTIMIZE Trial
37. Intravitreal Infliximab for Proliferative Vitreoretinopathy (FIXER)
38. Biologic Tapering Study of TNF Inhibitors in Axial Spondyloarthritis (BIOTAPE)
39. Treatment of Rheumatoid Arthritis With DMARDs: Predictors of Response
40. Evaluation of infliximab-induced genotoxicity and possible action on BCL-2 and P53 genes.
41. Comparative real-world outcomes between ustekinumab, infliximab, and adalimumab in bio-naïve and bio-experienced Crohn's disease patients: a retrospective multicenter study.
42. Optimising infliximab induction dosing to achieve clinical remission in Chinese patients with Crohn's disease.
43. 6‐Thioguanine nucleotide levels are associated with infliximab but not adalimumab levels in inflammatory bowel disease patients on combination therapy.
44. Infliximab in paediatric inflammatory bowel disease: External evaluation of population pharmacokinetic models.
45. Association Between Biologic Exposure and the Risk of Depression in Patients with Psoriasis: A Retrospective Analysis of Large US Administrative Claims Data.
46. Co-administration of 1,25-dihydroxyvitamin D3 and infliximab improves colitis in mice by modulating Treg differentiation.
47. Intravenous Versus Subcutaneous Infliximab in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
48. Impact of Value-Driven Healthcare Strategies for Biosimilar Adoption: The Singapore Story.
49. Pyodermatitis-pyostomatitis vegetans: a case report and systematic review focusing on oral involvement.
50. Intravenous Golimumab in the Treatment of Juvenile Idiopathic Arthritis and Its Associated Uveitis.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.